Molecular graphics and modeling methods illustrated the chemical background of the a priori approach from part I, and visualized steric and electronic enzyme-inhibitor relationships at qualitative and quantitative level for 34 and its derivatives. The enzyme-inhibitor electron density overlap occurs at 1.5-5.5Å cut-off distance, beyond van der Waals radii. Derivatives of 34 exhibit linear relationships between biological activity, molecular size and number of intermolecular interactions. © 2002 Elsevier Science Inc. All rights reserved.216499515Cohen, N.C., The molecular modeling perspective in drug design (1996) Guidebook on Molecular Modeling in Drug Design, pp. 1-17. , N.C. Cohen (Ed.), Academic Press, San DiegoHubbard, R.E., Molecular graphics and modeling: Tools of the trade (1996) Guidebook on Molecular Modeling in Drug Design, pp. 19-54. , N.C. Cohen (Ed.), Academic Press, San DiegoSelassie, C.D., Klein, T.E., Building bridges: QSAR and molecular graphics (2000) 3D QSAR in Drug Design: Theory, Methods and Applications, pp. 257-275. , H. Kubinyi (Ed.), Kluwer Academic Publisher, Dordrecht, The NetherlandsKlung, H.P., Alexander, L.E., (1974) X-ray Diffraction Procedures for Polycrystalline and Amorphous Materials, 2nd Ed., , Wiley, New YorkKiralj, R., Ferreira, M.M.C., QSAR of progestogens: Use of a priori and computed molecular descriptors and molecular graphics J. Chemometr., Quant. Struct.-Act. Relat., , in pressFerreira, M.M.C., Kiralj, R., Molecular graphics-structural and molecular graphics-descriptors in a QSAR study of 17-α-acetylprogesterones (2002) J. Braz. Chem. Soc., , Web available since 19 NovemberKiralj, R., Kojic-Prodic, B., Piantanida, I., Zinic, M., Crystal and molecular structures of diazapyrenes and a study of π···π interactions (1999) Acta Cryst., B55, pp. 55-69Ferreira, M.M.C., Kiralj, R., (2001) Proceedings of the 11th Simpósio Brasileiro de Química Teórica, p. 227. , Caxambu, MG, Brazil, 18-21 NovemberBeebe, K.R., Pell, R.J., Seasholtz, M.B., (1998) Chemometrics: A Pratical Guide, , Wiley, New York, NYFerreira, M.M.C., Kiralj, R., A priori molecular descriptors in QSAR: A case of HIV-1 protease inhibitors. I. Chemometrics (2003) J. Mol. Graphs. Mod., 21, pp. 435-448(1995) Insight II, Version 95.0, , Biosym/MSI Inc., San Diego, CA, USA(1997) WebLab Viewer, Version 2.01, , Molecular Simulations Inc., San Diego, CA, USABone, R., Vacca, J.P., Anderson, P.S., Holloway, M.K., X-ray crystal structure of the HIV-1 protease complex with L-700,417, an inhibitor with pseudo C2 symmetry (1991) J. Am. Chem. Soc., 113, pp. 9382-9384Jones, G., Willett, P., Glen, R.C., Leach, A.R., Taylor, R., Development and validation of a genetic algorithm for flexible docking (1997) J. Mol. Biol., 267, pp. 727-748. , http://www.ccdc.cam.ac.uk/prods/gold/gold.htmlThe Research Collaboratory for Structural Bioinformatics, , http://www.rcsb.org/pdb/, Rutgers, NJStewart, J.J.P., (1990) MOPAC, Version 6.0, , Frank Seiler Research Laboratory at Air Force Academy, Colorado Springs, ColoradoStewart, J.J.P., Reply to comments on a comparison of am1 with the recently developed PM3 method (1990) J. Comput. Chem., 11, pp. 534-544Stewart, J.J.P., Optimization of parameters for semiempirical methods. I. Method (1989) J. Comput. Chem., 10, pp. 209-220Stewart, J.J.P., Optimization of parameters for semiempirical methods. II. Applicatons (1989) J. Comput. Chem., 10, pp. 221-264Ferreira, M.M.C., Kiralj, R., New methods for Finding the Best Orientation in Molecular Graphics, , unpublished resultsClarke, C.K., Geography 115A/115AL: Introductory Air Photo Interpretation and Remote Sensing, Lecture 3: Scale and Area Measurement, , http://www.geog.ucsb.edu/~jeff/115a/, Department of Geography, University of California, Santa Barbara, CA, USARobinson, A.H., (1966) Elements of Cartography, 2nd Ed., p. 48. , Wiley, New York(2000) A Multipurpose Crystallographic Tool, Version 31000, , Spek, A.L. Utrecht University, Utrecht, The NetherlandsAllen, F.K., Kennard, O., Watson, D.G., Brammer, L., Orpen, G., Taylor, R., Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds (1987) J. Chem. Soc., Perkin Trans., 2, pp. 1-S19Gavezzotti, A., Molecular packing and correlations between molecular and crystal properties (1994) Structure Correlation, 2, pp. 509-542. , H.-B. Bürgi, J.D. Dunitz (Eds.), VCH Publishers, WeinheimPastor, M., Pérez, C., Gago, F., Simulation of alternative binding modes in a structure-binding based QSAR study of HIV-1 protease inhibitors (1997) J. Mol. Graphics Mod., 15, p. 389Pastor, M., Pérez, C., Gago, F., Simulation of alternative binding modes in a structure-binding based QSAR study of HIV-1 protease inhibitors (1997) J. Mol. Graphics Mod., 15, pp. 363-371Pácios, L.F., Analytical density-dependent representation of Hartree-Fock atomic potentials (1993) J. Comp. Chem., 14, pp. 410-421Bone, R., Vacca, J.P., Anderson, P.S., Holloway, M.K., X-ray crystal structure of the HIV-1 protease complex with L-700,417 an inhibitor with pseudo C2 symmetry (1991) J. Am. Chem. Soc., 113, pp. 9382-9384Kiralj, R., Ferreira, M.M.C., (2000) F77 Routines for Study of Inhibitor-Enzyme Interactions, , Instituto de Química, Universidade Estadual de Campinas, Campinas, SP, BrazilGavezzotti, A., Are crystal structures predictable? (1994) Acc. Chem. Res., 27, pp. 309-314Holloway, M.K., Wai, J.M., Halgren, T.A., Fitzgerald, P.M.D., Vacca, J.P., Dorsey, B.D., Levin, R.B., Zugay, J.A., A priori prediction of activiy for HIV-1 protease inhibitors employing energy minimization in the active site (1995) J. Med. Chem., 38, pp. 305-317(2000) Titan, Version 1, , Wavefunction Inc., Irvine, CAHalgren, T.A., Merck molecular force field. 1. Basis, form, scope, parameterization, and performance of MMFF94 (1996) J. Comp. Chem., 17, pp. 490-519Bader, W.F., (1990) Atoms in Molecules, p. 432. , Clarendon Press, OxfordSpiegel, M.R., (1967) Schaum's Outline of Theory and Problems of Theoretical Mechanics with Introduction to Langrange's Equation and Hamilton Theory, p. 255. , McGraw-Hill, New YorkKungl, A.J., Visser, N.V., Von Hoek, A., Visser, A.J.W.G., Billich, A., Schilk, A., Gstach, H., Auer, M., Time-resolved fluorescence anisotropy of HIV-1 protease inhibitor complexes correlated with inhibitor activity (1998) Biochemistry, 37, pp. 2778-2786Wlodawer, A., Vondrasek, J., Inhibitors of HIV-1 protease: A major success of structure-assisted drug design (1998) Annu. Rev. Biophys. Biomol. Struct., 27, pp. 249-284Pérez, C., Pastor, M., Ortiz, A.R., Gago, F., Comparative binding energy analysis of HIV-1 protease inhibitors: Incorporation of solvent effects and validation as a powerful tool in receptor-based drug design (1998) J. Med. Chem., 41, pp. 836-852Pattabiram, N., Occluded molecular surface analysis of ligand-macromolecule contacts: Application to HIV-1 protease inhibitor complexes (1999) J. Med. Chem., 42, pp. 3821-3834Zhang, C., Vasmatzis, G., Cornette, J.L., DeLisi, C., Determination of atomic desolvation energies from the structures of crystallized proteins (1997) J. Mol. Biol., 267, pp. 707-716Lian, C.Y., Robinson, H., Wong, A.H.-J., (1996) J. Am. Chem. Soc., 118, pp. 8791-8801Garg, R., Gupta, S.P., Gao, H., Baby, M.S., Debnath, A.K., Hansch, C., Comparative quantitative structure-activity relationship studies on anti-HIV drugs (1999) Chem. Rev., 99, pp. 3526-3601Friedman, S.H., DeCamp, D.L., Sijbesma, R.P., Srdanov, G., Wudl, F., Kenyon, G.L., Inhibition of the HIV-1 protease by Fullerene derivatives: Model building studies and experimental verification (1993) J. Am. Chem. Soc., 115, pp. 6506-6509Debnath, A.K., Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitor: Application of comparative molecular field analysis (1999) J. Med. Chem., 42, pp. 249-259Lunney, E.A., Hagen, S.E., Domagola, J.M., Humblet, C., Kosinski, J., Tait, B.D., Warmus, J.S., Erickson, J.W., A novel nonpeptide HIV-1 protese-inhibitor: Elucidation of the binding mode and its application in the design of related analogs (1994) J. Med. Chem., 37, pp. 2664-2677Liang, J., Edelsbrunner, H., Woodward, C., Anatomy of protein pockets and cavities - Measurement of binding site geometry and implications for ligand design (1998) Protein Sci., 7, pp. 1884-1897Sakurai, M., Higashida, S., Sugano, M., Handa, H., Komai, T., Yagi, R., Nishigaku, T., Yabe, Y., Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethane dipeptide isostere (1994) Chem. Pharm. Bull., 42, pp. 534-540Rellick, L.M., Becktel, W.J., Comparison of van der Waals and semiempirical calculations of the molecular volumes of small molecules and proteins (1997) Biopolymer, 42, pp. 191-202Bondi, A., Van der Waals, J., Volumes and radii (1964) Chem. Phys., 68, pp. 441-451Pácios, L.F., Atomic radii Scales and electron properties deduced from the charge density (1995) J. Comp. Chem., 16, pp. 133-145Mulichack, A.M., Hui, J.O., Tomasselli, A.G., Heinrikson, R.L., Curry, K.A., Tomich, C.-S., Thaisrivongs, S., Watenpaugh, K.D., The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptide transition state analog inhibitors (1993) J. Biol. Chem., 268, pp. 13103-13109Stahl, M., Böhm, H.-J., Development of filter functions for protein-ligand docking (1998) J. Mol. Graph., 16, pp. 121-132Abdel-Meguid, S.S., Metcalf, B.W., Carr, T.J., Demarsh, P., DesJarlais, R.L., Fisher, S., Green, D.W., Meek, T.D., An orally bioavailable HIV-1 protease inhibitors containing and imidazole-derived peptide bond replacement: Crystallographic and pharmacokinetic analysis (1994) Biochemistry, 33, pp. 11671-11677Klebe, G., Structure correlation and ligand/receptor binding (1994) Structure Correlation, 2, pp. 543-603. , H.-B. Bürgi, J.D., Dunitz (Eds.), VCH, Weinheim, GermanyHIV Protease Database, , http://www.ncifcrf.gov/HIVdb/, National Cancer Institute at Frederick, Frederick, NWDatabase for Anti-HIV compounds, , http://www.niaid.nih.gov/daids/dtpdb/, Bethesda, MA, US